IDH2 and cancer: Although the occurrence of IDH mutations alone seems to be insufficient to initiate the development of leukemia, the mere presence of IDH mutations leads to a block in the differentiation of hematopoietic stem cells and promotes the occurrence of further mutations that may initiate the cancer process [12,15].